Avalo Therapeutics (AVTX) Q3 2026 Earnings

30JulConfirmed
Q3 2025
Q4 2025
Q4 2025
Next
-2.19
-1.62
-1.05
-0.48

Details

Expected EPS
-0.902822
Actual EPS
N/A
Surprise EPS
0.9
Surprise Percent
+100%

Description

Avalo Therapeutics (AVTX) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts